The concordance rate between p53 IHC and TP53 mutation we observed reached the highest level at 81.5% when the IHC score standard was set at 80% of tumor cells, which suggests that TP53 mutation status could be utilized in defining p53 IHC patterns. This evidence concerns the gene TP53 and neoplasm.